| Long noncoding RNA associated-competing endogenous RNAs in gastric cancer T Xia, QI Liao, X Jiang, Y Shao, B Xiao, Y Xi, J Guo Scientific reports 4 (1), 6088, 2014 | 425 | 2014 |
| Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer Y Shao, M Ye, X Jiang, W Sun, X Ding, Z Liu, G Ye, X Zhang, B Xiao, ... Cancer 120 (21), 3320-3328, 2014 | 232 | 2014 |
| miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 Y An, Z Zhang, Y Shang, X Jiang, J Dong, P Yu, Y Nie, Q Zhao Cell Death & Disease 6 (5), e1766-e1766, 2015 | 215 | 2015 |
| Non-coding RNAs and gastric cancer PF Li, SC Chen, T Xia, XM Jiang, YF Shao, BX Xiao, JM Guo World journal of gastroenterology: WJG 20 (18), 5411, 2014 | 214* | 2014 |
| Long noncoding RNA FER1L4 suppresses cancer cell growth by acting as a competing endogenous RNA and regulating PTEN expression T Xia, S Chen, Z Jiang, Y Shao, X Jiang, P Li, B Xiao, J Guo Scientific reports 5 (1), 13445, 2015 | 161 | 2015 |
| Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms MY Huang, XM Jiang, BL Wang, Y Sun, JJ Lu Pharmacology & therapeutics 219, 107694, 2021 | 97 | 2021 |
| Chaperone-mediated autophagy regulates proliferation by targeting RND3 in gastric cancer J Zhou, J Yang, X Fan, S Hu, F Zhou, J Dong, S Zhang, Y Shang, X Jiang, ... Autophagy 12 (3), 515-528, 2016 | 91 | 2016 |
| The third Intensive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT3): an international, stepped wedge cluster randomised controlled trial L Ma, X Hu, L Song, X Chen, M Ouyang, L Billot, Q Li, A Malavera, X Li, ... The Lancet 402 (10395), 27-40, 2023 | 87 | 2023 |
| Low expression of lncRNA-HMlincRNA717 in human gastric cancer and its clinical significances Y Shao, H Chen, X Jiang, S Chen, P Li, M Ye, Q Li, W Sun, J Guo Tumor Biology 35, 9591-9595, 2014 | 78 | 2014 |
| Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells XM Jiang, YL Xu, MY Huang, LL Zhang, MX Su, X Chen, JJ Lu Acta Pharmacologica Sinica 38 (11), 1512-1520, 2017 | 68 | 2017 |
| Platycodin D triggers the extracellular release of programed death Ligand-1 in lung cancer cells MY Huang, XM Jiang, YL Xu, LW Yuan, YC Chen, G Cui, RY Huang, B Liu, ... Food and chemical toxicology 131, 110537, 2019 | 54 | 2019 |
| A global experiment on motivating social distancing during the COVID-19 pandemic N Legate, T Ngyuen, N Weinstein, A Moller, L Legault, Z Vally, ... Proceedings of the National Academy of Sciences 119 (22), 2022 | 53 | 2022 |
| Characterization of osimertinib (AZD9291)-resistant non-small cell lung cancer NCI-H1975/OSIR cell line ZH Tang, XM Jiang, X Guo, CMV Fong, X Chen, JJ Lu Oncotarget 7 (49), 81598, 2016 | 47 | 2016 |
| TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance X Jiang, Y Xu, L Yuan, L Zhang, M Huang, Z Ye, M Su, X Chen, H Zhu, ... Acta Pharmacologica Sinica 42 (3), 451-459, 2021 | 38 | 2021 |
| Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells LW Yuan, XM Jiang, YL Xu, MY Huang, YC Chen, WB Yu, MX Su, ZH Ye, ... Phytomedicine 80, 153394, 2021 | 38 | 2021 |
| Downregulation of Cyclin B1 mediates nagilactone E-induced G2 phase cell cycle arrest in non-small cell lung cancer cells LL Zhang, ZL Feng, MX Su, XM Jiang, X Chen, Y Wang, A Li, LG Lin, ... European Journal of Pharmacology 830, 17-25, 2018 | 32 | 2018 |
| Regulation of CD47 expression by interferon-gamma in cancer cells ZH Ye, XM Jiang, MY Huang, YL Xu, YC Chen, LW Yuan, CY Huang, ... Translational Oncology 14 (9), 101162, 2021 | 28 | 2021 |
| Increased expression of IRE1α associates with the resistant mechanism of osimertinib (AZD9291)-resistant non-small cell lung cancer HCC827/OSIR cells ZH Tang, MX Su, X Guo, XM Jiang, L Jia, X Chen, JJ Lu Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2018 | 22 | 2018 |
| Activation of notch 3/c-MYC/CHOP axis regulates apoptosis and promotes sensitivity of lung cancer cells to mTOR inhibitor everolimus T Li, XH Xu, X Guo, T Yuan, ZH Tang, XM Jiang, YL Xu, LL Zhang, X Chen, ... Biochemical Pharmacology 175, 113921, 2020 | 21 | 2020 |
| Nagilactone E suppresses TGF-β1-induced epithelial–mesenchymal transition, migration and invasion in non-small cell lung cancer cells LL Zhang, XM Jiang, MY Huang, ZL Feng, X Chen, Y Wang, H Li, A Li, ... Phytomedicine 52, 32-39, 2019 | 20 | 2019 |
Jin-Jian LuUniversity of MacauVerified email at um.edu.mo
